Shilpa Pharma – Your Trusted Global CDMO Partner
Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.
Social Networks
Useful Links
About Us
Capabilities
Sustainability
Events
Awards
Careers
Blogs
Sitemap
Contact us
Specialized Offerings
HPAPI
API
ADC Linkers
Polyethylene Glycol (PEGs)
Polymer Drug
ADC Payloads
CDMO Services
Peptides
Analytical Services
Drug Development
Corporate Office Address:
Shilpa Pharma Lifesciences Ltd.
#12-6-214/A1, Shilpa house, Hyderabad Road, Raichur – 584 135, Karnataka State, India.
Manufacturing Site Address:
Shilpa Pharma Lifesciences Limited 100% Export Oriented Unit.
Plot #33, 33A & 40 to 47, Raichur Growth Centre, Chicksugur Village, Raichur – 584134, Karnataka State, India. GSTIN: 29ABDCS6552L1ZR
Offering CDMO Services from Discovery to Commercialization
+91-9686397127
info@shilpapharma.com
SHILPA PHARMA GLOBAL PRESENCE
With a strong international footprint,
Shilpa Pharma
serves partners across key markets worldwide:
India
United States
Canada
China
Germany
France
Japan
Central America States
Brazil
Australia
Singapore
Taiwan
UAE
Saudi Arabia
South Korea
Russia
Egypt
South Africa
United Kingdom & Continental Europe
ROW Markets
Copyright © 2026 Shilpa Pharma. All Rights Reserved.
Developed by Scale Delight
Fill the Form
Name
Email
Your Contact Number
Job Title
Your Company
Select
Select Primary Interest Area
CDMO Services
High Potent API
Peptides
Polymers
Continuous Flow Chemistry
Formulation Development & Manufacturing
Biologics
Others
Country
Please Select Country
Afghanistan
Albania
Algeria
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Cabo Verde
Cambodia
Cameroon
Canada
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo (Congo-Brazzaville)
Costa Rica
Croatia
Cuba
Cyprus
Czechia (Czech Republic)
Democratic Republic of the Congo
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini (fmr. "Swaziland")
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Holy See
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar (formerly Burma)
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
North Korea
North Macedonia
Norway
Oman
Pakistan
Palau
Palestine State
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Sweden
Switzerland
Syria
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe
Message
Send Message